Pershing Square invests more in Valeant after controversy
November 23, 2015 at 20:19 PM EST
William Ackman’s Pershing Square Capital Management LP disclosed an increased stake in Valeant Pharmaceuticals, a move that comes after the hedge-fund manager said he had taken advantage of the beaten-down market for the stock to build up his position.